RHYTHM PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.68 USD | -2.73% |
|
-2.94% | -22.38% |
Chart calendar Rhythm Pharmaceuticals, Inc.
a3b8b23f67cd4.rIeon8jXOvjO7y2c4RrD-adPKuTKaI5CbKPNwJXvpl4.2vD-yZqRA5uAh1zohV2NuJMFeKWpCuk6Otn5n_mI5ySYw5DYiZUDyqC6Sg~a9c720c900c102a99e9f94ad6f1ff291
Upcoming events on Rhythm Pharmaceuticals, Inc.
Past events on Rhythm Pharmaceuticals, Inc.
| 2024-05-14 05:20 pm | BofA Securities Health Care Conference |
| 2024-05-07 08:00 am | Q1 2024 Earnings Call |
| 2024-05-07 07:00 am | Q1 2024 Earnings Release |
| 2024-05-01 | Pediatric Endocrine Society Meeting |
| 2024-04-09 02:15 pm | Needham Healthcare Conference |
| 2024-03-14 07:30 am | Barclays Global Healthcare Conference |
| 2024-03-05 02:50 pm | TD Cowen Health Care Conference |
| 2024-02-22 08:00 am | Q4 2023 Earnings Call |
| 2024-02-22 07:00 am | Q4 2023 Earnings Release |
| 2024-02-07 01:30 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 2023-12-06 08:00 am | R&D Day |
| 2023-11-15 02:25 pm | Stifel Healthcare Conference - Fireside Chat |
| 2023-11-07 08:00 am | Q3 2023 Earnings Call |
| 2023-11-07 07:00 am | Q3 2023 Earnings Release |
| 2023-10-18 08:00 am | The Obesity Society Meeting |
| 2023-09-20 | European Society for Paediatric Endocrinology Meeting |
| 2023-09-12 09:00 am | H.C. Wainwright Global Investment Conference |
| 2023-09-11 12:55 pm | Morgan Stanley Global Healthcare Conference |
| 2023-09-07 09:30 am | Wells Fargo Healthcare Conference |
| 2023-08-09 09:00 am | Canaccord Genuity Growth Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,22 - | 3,15 3,02 4.3% | 23,6 21,4 10.58% | 77,4 78,8 -1.74% | 123 |
|
EBITDA Million USD | Released Forecast Spread | -145 -147 1.08% | -136 -144 5.71% | -169 -161 -5.22% | -177 -177 -0.19% | -183 -179 -1.88% | -258 |
|
EBIT Million USD | Released Forecast Spread | -146 -151 3.33% | -137 -140 2.14% | -170 -167 -2.06% | -179 -182 1.75% | -184 -185 0.32% | -273 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -141 -146 3.63% | -134 -136 1.14% | -69,6 -66,6 -4.44% | -181 -184 1.68% | -184 -185 0.28% | -274 |
|
Net income Million USD | Released Forecast Spread | -141 -146 3.55% | -134 -135 0.49% | -69,6 -72,9 4.46% | -181 -184 1.5% | -185 -185 -0.05% | -275 |
|
EPS USD | Released Forecast Spread | -3,86 -3,93 1.71% | -3,04 -3,04 -0.09% | -1,40 -1,46 4.24% | -3,47 -3,55 2.12% | -3,20 -3,21 0.43% | -4,44 |
| Announcement Date | 02/03/20 | 01/03/21 | 01/03/22 | 01/03/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,50 2,30 -34.87% | 9,07 2,57 253.38% | 4,28 4,76 -10.02% | 8,79 7,16 22.84% | 11,5 12,1 -5.36% | 19,2 15,0 27.9% | 22,5 22,2 1.47% | 24,2 25,4 -4.51% | 26,0 26,9 -3.45% | 29,3 | 32,4 | 35,8 | 40,2 | 39,7 |
|
EBIT Million USD | Released Forecast Spread | -52,7 -52,1 -1.05% | -45,1 -52,8 14.54% | -39,3 -51,4 23.65% | -42,1 -45,7 7.89% | -52,5 -41,3 -27.28% | -46,6 -44,1 -5.63% | -44,0 -43,9 -0.2% | -41,3 -42,3 2.45% | -140 -126 -11.02% | -44,3 | -48,8 | -44,1 | -39,6 | -34,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -52,8 -51,8 -1.91% | -45,0 -52,8 14.73% | -40,9 -50,8 19.49% | -42,5 -46,8 9.28% | -52,2 -40,4 -29.08% | -46,7 -47,3 1.16% | -43,8 -43,8 -0.03% | -41,4 -43,3 4.42% | -141 -113 -24.57% | -43,4 | -50,4 | -42,6 | ||
|
Net income Million USD | Released Forecast Spread | -52,8 -51,8 -1.89% | -45,0 -52,9 14.9% | -40,9 -51,6 20.81% | -42,5 -45,8 7.32% | -52,2 -40,8 -27.92% | -46,7 -44,1 -5.91% | -44,2 -44,7 1.24% | -41,6 -42,2 1.37% | -141 -123 -14.63% | -44,1 | -49,4 | -44,0 | -36,8 | -34,6 |
|
EPS USD | Released Forecast Spread | -1,05 -1,01 -3.83% | -0,89 -0,95 6.17% | -0,79 -1,01 21.56% | -0,74 -0,82 9.34% | -0,92 -0,71 -30.37% | -0,82 -0,78 -4.63% | -0,76 -0,76 -0.16% | -0,70 -0,71 1.75% | -2,35 -2,02 -16.63% | -0,70 | -0,77 | -0,67 | -0,59 | -0,55 |
| Announcement Date | 03/05/22 | 02/08/22 | 08/11/22 | 01/03/23 | 02/05/23 | 01/08/23 | 07/11/23 | 22/02/24 | 07/05/24 | - | - | - | - | - |
More events
Past sector events for Rhythm Pharmaceuticals, Inc.
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RYTM Stock
- Calendar Rhythm Pharmaceuticals, Inc.
